Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Is the SHROOM3 rs13146355 variant linked to lower serum magnesium?

Carriage of the SHROOM3 rs13146355 variant is associated with lower serum magnesium concentrations in population genetic studies.

PlausibleJune 19, 20267 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

The SHROOM3 rs13146355 variant is associated with lower serum magnesium in population studies.

laying out figure…
1 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

Population-scale genetic analyses repeatedly link the rs13146355 allele at SHROOM3 to reduced systemic magnesium. The proposed mechanism frames this effect as altered renal tubular structure or paracellular handling that decreases renal magnesium reabsorption and thereby lowers serum levels.

Verified conclusion

Large-scale genetic studies have consistently identified the SHROOM3 locus as a primary determinant of systemic magnesium levels. As magnesium is essential for numerous physiological processes, including enzymatic function and neurological stability, understanding these genetic influencers provides critical insight into individual baseline variations.

Clinical and population evidence

Population-level data from genome-wide association studies (GWAS) and subsequent meta-analyses provide robust evidence linking SHROOM3 variants to serum magnesium concentrations:

  • Meta-Analysis Data: In a large-scale meta-analysis of over 15,000 individuals of European descent, the SHROOM3 locus was identified as one of six significant genomic regions associated with serum magnesium levels, achieving a high level of statistical significance (p = 2.9 × 10⁻²⁷).
  • Variant Specificity: While multiple variants exist at this locus, rs13146355 is frequently identified as the lead single nucleotide polymorphism (SNP) characterizing this association. Carriage of the risk allele is linked to significantly lower serum magnesium concentrations compared to non-carriers.
  • Diverse Populations: The association has been replicated across various demographics, including African-American cohorts and specific patient populations such as those with type 2 diabetes, suggesting a highly conserved biological relationship between this gene and magnesium homeostasis.

Mechanistic explanations

The influence of SHROOM3 on magnesium is primarily mediated through renal physiology rather than dietary absorption:

  • Renal Structural Integrity: SHROOM3 encodes a protein critical for regulating actin dynamics and apical constriction, which are essential for maintaining the structural architecture of epithelial cells.
  • Electrolyte Handling: In the kidney, magnesium is filtered and then reabsorbed largely through paracellular pathways in the proximal tubule and the thick ascending limb. SHROOM3 is robustly associated with other renal markers, including estimated glomerular filtration rate (eGFR) and albuminuria, indicating it plays a central role in tubular function and electrolyte transport.
  • Cellular Architecture: Researchers hypothesize that SHROOM3 affects magnesium levels by modulating the paracellular "leakiness" or transport efficiency of the renal tubules, though the exact interaction with specific magnesium transporters remains a focus of ongoing research.

Bottom line

The association between the SHROOM3 rs13146355 variant and lower serum magnesium is well-supported by robust population genetics. This relationship likely stems from the gene's fundamental role in renal tubular architecture and its subsequent impact on how the kidneys reabsorb magnesium from the filtrate.

References

  1. The Good and the Bad of SHROOM3 in Kidney Development and Disease: A Narrative Review — pmc.ncbi.nlm.nih.gov ↗
  2. The Good and the Bad of SHROOM3 in Kidney Development and Disease: A Narrative Review — journals.sagepub.com ↗
  3. Magnesium Homeostasis: Lessons from Human Genetics. — pmc.ncbi.nlm.nih.gov ↗
  4. Regulation of magnesium balance: lessons learned from human genetic disease — pmc.ncbi.nlm.nih.gov ↗
  5. Genome-Wide Association Studies of Serum Magnesium, Potassium, and Sodium Concentrations Identify Six Loci Influencing Serum Magnesium Levels — pmc.ncbi.nlm.nih.gov ↗
  6. Genome-wide association study of serum magnesium in type 2 diabetes — genesandnutrition.biomedcentral.com ↗
  7. Genome-wide association study of serum magnesium in type 2 diabetes — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→